These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 22917547

  • 61. Effects of renal denervation on end organ damage in hypertensive patients.
    Verloop WL, Vink EE, Spiering W, Blankestijn PJ, Doevendans PA, Bots ML, Vonken EJ, Voskuil M, Leiner T.
    Eur J Prev Cardiol; 2015 May; 22(5):558-67. PubMed ID: 25326543
    [Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63. Selective proximal renal denervation guided by autonomic responses evoked via high-frequency stimulation in a preclinical canine model.
    Lu J, Wang Z, Zhou T, Chen S, Chen W, Du H, Tan Z, Yang H, Hu X, Liu C, Ling Z, Liu Z, Zrenner B, Woo K, Yin Y.
    Circ Cardiovasc Interv; 2015 Jun; 8(6):. PubMed ID: 26058393
    [Abstract] [Full Text] [Related]

  • 64. Renal Nerve Stimulation as Procedural End Point for Renal Sympathetic Denervation.
    Hoogerwaard AF, de Jong MR, Elvan A.
    Curr Hypertens Rep; 2018 Mar 19; 20(3):24. PubMed ID: 29556850
    [Abstract] [Full Text] [Related]

  • 65. Atrial fibrillation reduction by renal sympathetic denervation: 12 months' results of the AFFORD study.
    Feyz L, Theuns DA, Bhagwandien R, Strachinaru M, Kardys I, Van Mieghem NM, Daemen J.
    Clin Res Cardiol; 2019 Jun 19; 108(6):634-642. PubMed ID: 30413869
    [Abstract] [Full Text] [Related]

  • 66. Potential role of renal sympathetic denervation for the treatment of cardiac arrhythmias.
    Ukena C, Mahfoud F, Linz D, Böhm M, Neuberger HR.
    EuroIntervention; 2013 May 19; 9 Suppl R():R110-6. PubMed ID: 23732141
    [Abstract] [Full Text] [Related]

  • 67. Prevalence of resistant hypertension and eligibility for catheter-based renal denervation in hypertensive outpatients.
    Hayek SS, Abdou MH, Demoss BD, Legaspi JM, Veledar E, Deka A, Krishnan SK, Wilmot KA, Patel AD, Kumar VR, Devireddy CM.
    Am J Hypertens; 2013 Dec 19; 26(12):1452-8. PubMed ID: 23934709
    [Abstract] [Full Text] [Related]

  • 68. Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension.
    Dorenkamp M, Bonaventura K, Leber AW, Boldt J, Sohns C, Boldt LH, Haverkamp W, Frei U, Roser M.
    Eur Heart J; 2013 Feb 19; 34(6):451-61. PubMed ID: 23091202
    [Abstract] [Full Text] [Related]

  • 69. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.
    Symplicity HTN-1 InvestigatorsCentre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University/Alfred Hospital, Melbourne, Victoria 3004, Australia. henry.krum@med.monash.edu.au.
    Hypertension; 2011 May 19; 57(5):911-7. PubMed ID: 21403086
    [Abstract] [Full Text] [Related]

  • 70. Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity system.
    Kaiser L, Beister T, Wiese A, von Wedel J, Meincke F, Kreidel F, Busjahn A, Kuck KH, Bergmann MW.
    EuroIntervention; 2014 May 19; 10(1):157-65. PubMed ID: 24472799
    [Abstract] [Full Text] [Related]

  • 71. Effects of multielectrode renal denervation on cardiac and neurohumoral adaptations in resistant hypertension with cardiac hypertrophy: an EnligHTN I substudy.
    Tsioufis C, Papademetriou V, Dimitriadis K, Tsiachris D, Thomopoulos C, Kasiakogias A, Kordalis A, Kefala A, Koutra E, Lau EO, Grassi G, Stefanadis C.
    J Hypertens; 2015 Feb 19; 33(2):346-53. PubMed ID: 25380167
    [Abstract] [Full Text] [Related]

  • 72. Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension.
    Geisler BP, Egan BM, Cohen JT, Garner AM, Akehurst RL, Esler MD, Pietzsch JB.
    J Am Coll Cardiol; 2012 Oct 02; 60(14):1271-7. PubMed ID: 22981547
    [Abstract] [Full Text] [Related]

  • 73. Effects of renal denervation on coronary flow reserve and forearm dilation capacity in patients with treatment-resistant hypertension. A randomized, double-blinded, sham-controlled clinical trial.
    Engholm M, Bertelsen JB, Mathiassen ON, Bøtker HE, Vase H, Peters CD, Bech JN, Buus NH, Schroeder AP, Rickers H, Hansen KW, Poulsen PL, Kaltoft A, Christensen KL.
    Int J Cardiol; 2018 Jan 01; 250():29-34. PubMed ID: 29042091
    [Abstract] [Full Text] [Related]

  • 74. Blood pressure response to renal denervation is correlated with baseline blood pressure variability: a patient-level meta-analysis.
    Persu A, Gordin D, Jacobs L, Thijs L, Bots ML, Spiering W, Miroslawska A, Spaak J, Rosa J, de Jong MR, Berra E, Fadl Elmula FEM, Wuerzner G, Taylor AHM, Olszanecka A, Czarnecka D, Mark PB, Burnier M, Renkin J, Kjeldsen SE, Widimský J, Elvan A, Kahan T, Steigen TK, Blankestijn PJ, Tikkanen I, Staessen JA, European Network COordinating research on Renal Denervation (ENCOReD).
    J Hypertens; 2018 Feb 01; 36(2):221-229. PubMed ID: 29045339
    [Abstract] [Full Text] [Related]

  • 75. Impact of local vascular lesions assessed with optical coherence tomography and ablation points on blood pressure reduction after renal denervation.
    Ghadri JR, Gaehwiler R, Jaguszewski M, Sudano I, Osipova J, Schoenenberger-Berzins R, Erne P, Lüscher TF, Templin C.
    Swiss Med Wkly; 2015 Feb 01; 145():w14102. PubMed ID: 25658048
    [Abstract] [Full Text] [Related]

  • 76. Blood pressure response to renal nerve stimulation in patients undergoing renal denervation: a feasibility study.
    Gal P, de Jong MR, Smit JJ, Adiyaman A, Staessen JA, Elvan A.
    J Hum Hypertens; 2015 May 01; 29(5):292-5. PubMed ID: 25339295
    [Abstract] [Full Text] [Related]

  • 77. Renal denervation reduces office and ambulatory heart rate in patients with uncontrolled hypertension: 12-month outcomes from the global SYMPLICITY registry.
    Böhm M, Ukena C, Ewen S, Linz D, Zivanovic I, Hoppe U, Narkiewicz K, Ruilope L, Schlaich M, Negoita M, Schmieder R, Williams B, Zeymer U, Zirlik A, Mancia G, Mahfoud F, Global SYMPLICITY Registry Investigators.
    J Hypertens; 2016 Dec 01; 34(12):2480-2486. PubMed ID: 27755390
    [Abstract] [Full Text] [Related]

  • 78. Effects of Renal Denervation on Sympathetic Nerve Traffic and Correlates in Drug-Resistant and Uncontrolled Hypertension: A Systematic Review and Meta-Analysis.
    Biffi A, Dell'Oro R, Quarti-Trevano F, Cuspidi C, Corrao G, Mancia G, Grassi G.
    Hypertension; 2023 Mar 01; 80(3):659-667. PubMed ID: 36628971
    [Abstract] [Full Text] [Related]

  • 79. Role of Adding Spironolactone and Renal Denervation in True Resistant Hypertension: One-Year Outcomes of Randomized PRAGUE-15 Study.
    Rosa J, Widimský P, Waldauf P, Lambert L, Zelinka T, Táborský M, Branny M, Toušek P, Petrák O, Čurila K, Bednář F, Holaj R, Štrauch B, Václavík J, Nykl I, Krátká Z, Kociánová E, Jiravský O, Rappová G, Indra T, Widimský J.
    Hypertension; 2016 Feb 01; 67(2):397-403. PubMed ID: 26693818
    [Abstract] [Full Text] [Related]

  • 80. Effects of electrical stimulation of carotid baroreflex and renal denervation on atrial electrophysiology.
    Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K, Böhm M.
    J Cardiovasc Electrophysiol; 2013 Sep 01; 24(9):1028-33. PubMed ID: 23638844
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.